ea0063p1074 | Pituitary and Neuroendocrinology 3 | ECE2019
Hage Mirella
, Marin Cristi
, Bakopoulou Sophia
, Marcellus Capucine De
, Guyot Alexis
, Gaillard Stephan
, Raffin-Sanson Marie Laure
, Cazabat Laure
Background: Somatostatin analogues are the mainstay medical treatment of acromegaly. Side effect of this treatment includes gastrointestinal disturbances, cholelithiasis, and local reactions at injection sites. Herein we report an unusual case of local myofascitis after one-year treatment with deep subcutaneous injections of lanreotide Autogel in a patient with acromegalo-gigantism.Clinical case: A 25-year-old man was found to have an invasive macroadeno...